SUMMARY
Ten patients with small supratentorial tumours were studied during craniotomy. Cerebral blood flow (CBF) anaesthesia, all patients were awake, ASA group I -II and were receiving treatment with steroids.
Anaesthesia
One hour before the induction of anaesthesia the patients were premedicated with pentobarbitone 2 mg kg" 1 i.m., and mepyramine 50 mg i.m. and cimetidine 400 mg by mouth. After preoxygenation, anaesthesia was induced with an infusion of Althesin at a rate of 1.0 ml kg" 1 h" 1 and fentanyl 0.2 mg i.v. Pancuronium 0.10-0.15 mg kg" 1 was given to produce neuromuscular blockade, manual hyperventilation was applied and tracheal intubation performed. From the point of intubation until the end of the first CBF measurement, the anaesthesia was maintained with a continuous infusion of Althesin 0.2 ml kg" 1 h" 1 , 66% nitrous oxide in oxy-gen and fentanyl in doses of 0.1 mg (total 7.8 ± 2.8 ^g kg' 1 (mean ± SD)). In five patients the rate of infusion of Althesin was 0.2 ml kg" 1 h" 1 throughout the study, and CBF was measured on two occasions. In four patients the Althesin infusion rate was increased to 0.5 ml kg" 1 h" 1 30 min before the second CBF determination. In one patient (No. 10, table I) the infusion of Althesin was unintentionally disrupted 30 min before the second CBF measurement. Ventilation was controlled throughout (Servo 900 B) and end-expiratory carbon dioxide concentration monitored. 
Measurements of CBF, CMRo 2 and EEG
The internal jugular vein contralateral to the tumour was cannulated percutaneously using the anterior approach, and a catheter placed at the base of the skull. The position of the catheter was confirmed radiologically. Xenon-133 2 mCi in saline was infused i. v. over a period of 20 min to obtain saturation. Blood samples (2 ml precisely) were drawn using disposable syringes from arterial and jugular venous blood at exact time intervals of 18,19 and 20 min during saturation and at 1, 2, 3, 4, 5, 7, 9, 11, 13, 15, 20, 25 and 30 min during desaturation. Radioactivity in the samples was counted, and the arterial and venous desaturation curves drawn ( fig.  1 ). The amount of xenon-133 released by the brain during the 30-min desaturation period was estimated by planimetry as the area between the arterial and venous desaturation curves. CBF was calculated using the "Height-over-Area" formula (CBF 30 ) and cerebral metabolic rate of oxygen (CMRo 2 ) from the product of CBF and the arterio-venous oxygen difference (Kety and Schmidt, 1948; Lassen and Klee, 1965; Astrup et al., 1984) . The partition coefficient for brain tissue was corrected for haemoglobin concentration (Veall and Mallet, 1965) . The first CBF measurement was performed about 1 h after the induction of anaesthesia, and the second approximately 1 h later. At least 30 min was allowed to elapse after the increase in the Althesin infusion rate before xenon-133 desaturation and hence the CBF and CMRO 2 measurements.
After the induction of anaesthesia, eight EEG electrodes were positioned over the frontal, temporal and occipital regions on the side contralateral to the craniotomy. A 2-min EEG recording was obtained during each xenon-133 desaturation period, while surgery was discontinued to avoid electrical interference with the recording. The EEG recordings were compared with the preoperative EEG and analysed as described by Prior, Maynard and Brierley (1978) , using a six-point scale. Level one corresponded to continuous background activity of fairly constant voltage with any combinations of frequency, but without periods of either partial or total suppression. Level two: periods of less than 1 s total or subtotal suppression, separated by bursts of activity usually of 100-300 |xV. Level three: periods of 1-3 s duration of total, occasional subtotal suppression, separated by bursts of activity of 100-300 (iV. Level four: periods of at least 3 s total suppression separated by bursts of activity usually of 50-100 \iV. Level five: periods of at least 3 s total suppression separated by very brief bursts of low voltage less than 50 uV. Level six: no evidence of any cerebral electrical activity even with high gain. This scale, although initially designed for animal experiments with extradurally-placed electrodes, has subsequently been applied in man during the infusion of Althesin (Henderson, McGeorge and Teasdale, 1982) .
Assay for alphaxalone in plasma
These analyses were performed at Glaxo Group, Research Limited, Greenford, Middlesex. Plasma alphaxalone was analysed in peripheral arterial blood sampled during each CBF measurement at the time of the EEG recording; plasma was stored at -25°C until assayed.
Plasma, to which internal standard (2(3-n-butoxy, 3a-hydroxy-5a-pregnane-ll, 20-dione 1 fig) had been added, was buffered to pH 11.4 and extracted with ether. The extract was evaporated to dryness and then derivatized with heptafluorobutyrylimidazole in toluene (10 min 55 °C).
Excess reagent was removed by washing with buffer (pH 7.4). The derivative was diluted with toluene before gas-liquid chromatography (GLC) on 2% Dexsil 300 at 245 °C. Detection was by ECD, and quantitation was by the peak -height ratio method. Assay sensitivity was 20 ng ml" 1 provided a rigorous conditioning procedure was applied to the GLC column before use. This involved injections of 2, 4-pentanedione and Silyl-8 onto the column at 250 °C and subsequent overnight heating at 290 °C.
Arterial pressure was monitored and the mean pressure (MAP) recorded continuously, as was rectal temperature. Arterial blood-gas analyses were performed twice during each CBF measurement (ABL 1: Radiometer). The oxygen saturations of arterial and jugular venous blood were measured in duplicate (OSM2: Radiometer).
Statistical analyses
The results are indicated as mean ± standard deviation (SD). P < 0.05 indicates level of significance. The Mann-Whitney test was used for unpaired data; Student's t test for paired data. Linear regression and correlation coefficients were used for correlations between two variables.
RESULTS
During the first CBF study at an Althesin infusion rate of 0.02 ml kg" 1 h" 1 (n = 10), CBF was 24.4 ± 5.4 ml min-VlOO g and CMRo 2 1.87 ± 0.44 ml mhr'/lOO g at Pa C o 4.1 ± 0.7 kPa and body temperature 35.7 ± 0.4 ^C.
In five studies at an unchanged infusion rate of 0.2 ml kg" 1 h" 1 , the changes in CBF and CMRO 2 were from 21.8 ± 5.0 to 20.0 ± 6.4 ml min" 1 / 100 g and from 1.84 + 0.20 to 1.88 ±0.80 ml min-'/lOO g, respectively (table I) . During the second CBF measurement (infusion rate 0.5 ml kg" 1 h" 1 (patients Nos 6-9, table I)) CBF decreased from 25.0 ± 5.7 to 20.1 ± 8.6 ml min" 1 / 100 g and CMRO 2 from 1.85 1 0 . 7 1 to 1.50 ± 0.30 ml min-'/lOO g. The decrease in CMRO 2 was greater than 15% in three patients while a small increase was found in one patient. In one figure 2 . As indicated, CMRO 2 never decreased below 1.6 ml min'VlOO g at EEG level 1, and CMRo 2 did not surpass 2.1 ml if EEG traces were level 3 or more. In three patients a decrease in CMRo 2 was associated with suppression of EEG activity. In six patients a decrease in CMRo 2 was observed while the EEG level was unchanged, and in one patient suppression of EEG activity was found with an unchanged CMRo 2 . Relationship between changes in plasma alphaxalone concentration ((ig ml"') and CMRo 2 (ml mur'/lOO g) measured on the contralateral hemisphere during craniotomy for cerebal tumour.
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The correlations between corresponding values of plasma alphaxalone and CMRo 2 are shown in figure  3 . In six patients, an increase in plasma alphaxalone was associated with a decrease in CMRo 2 ; in three patients with an increase in CMR0 2 ; in one patient, unchanged plasma alphaxalone concentration was observed at two different values of CMRo 2 . As in figure 2 , great inter-and intraindividual differences in the relationship was found. In total (n = 20) the correlation between plasma alphaxalone concentration and CMRo 2 was insignificant.
The relationship between changes in plasma alphaxalone concentration and EEG level is shown in figure 4 . Again, great inter-and intraindividual differences were observed. In only three patients was an increase in plasma alphaxalone concentration associated with a suppression of EEG activity; in six patients unchanged EEG activity was observed at different alphaxalone concentrations and in one patient a suppression of EEG activity was associated with unchanged plasma alphaxalone concentration. ) and EEG level. EEG was obtained from the contralateral hemisphere during craniotomy for cerebral tumour.
The increase in infusion rate was associated with a decrease in EEG activity in two patients, and an unchanged level in two other patients. A decrease in CMR0 2 was observed in three of four patients, and an increase in plasma alphaxalone concentration in all four patients (table I) .
DISCUSSION
The method used in this study to measure CBF and CMRo 2 is a modification of the inhalation method described by Kety and Schmidt (1948) . We Downloaded from https://academic.oup.com/bja/article-abstract/57/4/369/275059 by guest on 07 January 2019 measured CBF in the contralateral hemisphere of the tumour because regional flow differences usually seen in cerebral hemisphere with tumours (Palvolgyi, 1969) would invalidate the result of hemispheric studies. The effect of the tumour on CBF and CMRo 2 in the contralateral hemisphere is not known, but by restricting the measurements to patients who were fully alert before surgery and showing only a moderate mass effect of the tumour, the influence of the contralateral hemisphere was assumed to be minimal. Therefore, we assumed that intracranial pressure in the contralateral hemisphere was low and would only influence the cerebral circulation and metabolism to a minor degree. In a recent study of CBF and CMRo 2 in awake unpremedicated patients with supratentorial tumours, we used the i.v. modification of Kety and Schmidt as described in the present study, and obtained CBF values of 47 ml min-'/lOO g and CMRO 2 of 3.3 ml min" 1 / 100 g (Astrupetal., 1984) . These values correspond to the values found in normal man (Lassen, 1959) , and argue against a major influence of the tumour on the contralateral hemisphere. Nevertheless, methodological errors may occur. These errors include contamination with extracranial blood and blood from the contralateral hemisphere (Lassen, 1959; Lassen and Lane, 1961) . Furthermore, contamination by central venous blood also occurs (Murray, Hoschl and Choy, 1978) . The last mentioned error is a function of the difference in pressure between central venous blood and the pressure in the jugular bulb, and might be eliminated by keeping the inspiratory pressure as low as possible. In the present study we used a respiratory frequency of about 20 b.p.m., and the inspiratory phase of the respiratory cycle was constant at 30%. This study presumes that steady-state conditions pertain during the 30-min desaturation period. This assumption was fulfilled as far as Paco was concerned, but the mean arterial pressure did increase during the operative procedure, especially on incision of the skin. Thus, the nociceptive stimulation induced by the operation might influence the measurements. According to Kuramoto and others (1979) , nerve stimulation will increase EEG activity and CMRo 2 in anaesthetized dogs. However, in all of the patients the first CBF measurement was commenced before the dura was opened, while the second measurement was performed during the operative evacuation of the tumour. Red cerebral veins have often been seen during craniotomy in patients with cerebral tumours (Feindal and Perot, 1965) . This hyperoxygenation of the venous blood can arise suddenly, and is often provoked by the operative procedure. If a hemispheric luxury syndrome does occur (Lassen, 1966) on the tumour site, the high venous oxygen saturation will result in an underestimation of CMRo 2 as a result of contamination of the contralateral hemisphere. In the present study this might explain the low values of CMRO 2 (< 1.4 ml min~'/100 g) found in three studies of CBF.
The present study indicates that Althesin decreases CBF and CMRO 2 . This is in accordance with studies in baboons (Pickerodt et al., 1972) and humans (Renou et al., 1976; Sari et al., 1976; Rasmussen, Rosendal and Overgaard, 1978) . Sari and colleagues (1976) found CBF values of 29 ml min" 1 / 100 g at Pa C o 2 4.8 kPa during continuous Althesin infusion at a rate of 0.3 ml kg" 1 h" 1 . According to Sari and colleagues (1976) , cerebral carbon dioxide reactivity is maintained during Althesin anaesthesia, and this might be the explanation for the lower values of CBF in the present study, as Pa C o 2 was kept lower. Like Sari and colleagues (1976), we found considerable interindividual variation in CBF and CMRO 2 . The reason could be methodological errors and difficulties in maintaining steady-state conditions during the measurements. This, together with the restricted number of investigations and a great individual difference in sensitivity to Althesin might explain the lack of correlation between CMRo 2 , EEG and plasma alphaxalone concentration.
After increasing the infusion rate from 0.2 to 0.5 ml kg" 1 h~', we found an increase in plasma alphaxalone concentration in four studies and suppression of EEG activity in only two of four patients. The results confirm the studies by Henderson, McGeorge and Teasdale (1982) who found a correlation between rate of infusion of Althesin and suppression in EEG, and the studies by Frank and colleagues (1982) who found a significant correlation between plasma alphaxalone concentration and cerebral function monitor trace. In addition, our results are a confirmation of the study performed by Sear and Prys-Roberts (1979) , who found an almost linear correlation between the rate of infusion of Althesin and plasma alphaxalone concentration. The paradoxical association of increased plasma alphaxalone concentration and increased CMRO 2 found in three patients may be caused by methodological errors in the estimation of CMRO 2 , or absence of steady-state conditions as a result of the operative procedure.
Neuroanaesthesia using a continuous infusion of Althesin produces a dose-dependent decrease in
